Using mHealth applications for self-care – An integrative review on perceptions among adults with type 1 diabetes

Background Individually designed interventions delivered through mobile health applications (mHealth apps) may be able to effectively support diabetes self-care. Our aim was to review and synthesize available evidence in the literature regarding perception of adults with type 1 diabetes on the features of mHealth apps that help promote diabetes self-care, as well as facilitators and barriers to their use. An additional aim was to review literature on changes in patient reported outcome measures (PROMs) in the same population while using mHealth apps for diabetes self-care. Methods Quantitative and qualitative studies focusing on adults aged 18 years and over with type 1 diabetes in any context were included. A systematic literature search using selected databases was conducted. Data was synthesised using narrative synthesis. Results We found that features of mHealth apps designed to help promote and maintain diabetes self-care could be categorized into self-care data monitoring, app display, feedback & reminders, data entry, data sharing, and additional features. Factors affecting the use of mHealth apps reported in the literature were personal factors, app design or usability factors, privacy and safety factors, or socioeconomic factors. Quality of life and diabetes distress were the most commonly reported PROMs in the included studies. Conclusion We are unable to reach a conclusive result due to the heterogeneity of the included studies as well as the limited number of studies reporting on these areas among adults with type 1 diabetes. We therefore recommend further large-scale studies looking into these areas that can ultimately improve mHealth app use in type 1 diabetes self-care.publishedVersio

Enhancing diabetes self-management through mobile phone application

Mary Adu adopted a systematic health behavioural framework and user engagement process to develop and explore the efficacy of a novel mobile-phone app for diabetes self-management. Reported benefits of the app provide empirical evidence of support for its multi-feature functionality and comprehensive interventional role in diabetes self-management education and support

Mobile application resources to selfcare and selfmanagement of type i diabetes mellitus: integrative review / Recursos de aplicativos móveis para autocuidado e autogerenciamento do diabetes mellitus tipo i: revisão integrativa

Objetivo: identificar os recursos disponíveis em aplicativos móveis que favoreçam o autocuidado e o autogerenciamento do Diabetes Mellitus tipo I. Método: trata-se de uma revisão integrativa realizada nas bases de dados: BVS, PubMed e Scopus, com os descritores Diabetes Mellitus AND Aplicativos móveis, nos idiomas português, espanhol e inglês. Resultados: foram analisados 16 artigos e neles identificados os principais recursos para o autocuidado e o autogerenciamento do Diabetes Mellitus tipo I: glicosímetro, diário digital de diabetes, ações corretivas de glicose, controle alimentar e comunicação entre usuário e profissional de saúde e usuário com seus pares. Conclusões: evidenciou-se a escassez de estudos cujo público alvo são pessoas que convivem com Diabetes Mellitus tipo I. Os resultados indicam que os recursos identificados nos aplicativos para dispositivos móveis auxiliam os indivíduos com Diabetes Mellitus tipo I no autocuidado e autogerenciamento da doença

Mobile Health Technologies

Mobile Health Technologies, also known as mHealth technologies, have emerged, amongst healthcare providers, as the ultimate Technologies-of-Choice for the 21st century in delivering not only transformative change in healthcare delivery, but also critical health information to different communities of practice in integrated healthcare information systems. mHealth technologies nurture seamless platforms and pragmatic tools for managing pertinent health information across the continuum of different healthcare providers. mHealth technologies commonly utilize mobile medical devices, monitoring and wireless devices, and/or telemedicine in healthcare delivery and health research. Today, mHealth technologies provide opportunities to record and monitor conditions of patients with chronic diseases such as asthma, Chronic Obstructive Pulmonary Diseases (COPD) and diabetes mellitus. The intent of this book is to enlighten readers about the theories and applications of mHealth technologies in the healthcare domain

Supporting Diabetes Self-Management with Ubiquitous Computing Technologies: A User-Centered Inquiry

Ubiquitous computing technologies offer opportunities to improve treatments for chronic health conditions. Type 1 diabetes is a compelling use-case for such approaches, given its severity, and need for individuals to make frequent care decisions, informed by complex data. However, current apps, typically based on effortful reflection on collected data, generally show poor adoption, lack vital cognitive and emotional support, and are poorly tailored to users’ actual diabetes decision making processes. This thesis investigates how diabetes apps can be improved from a user-centered perspective. An initial questionnaire-based study investigated how well existing diabetes apps meet user needs. Perceived benefits, limitations, and reasons for low adoption rates were identified. A talk-aloud study of detailed user interactions with diabetes logging apps was conducted to characterize the benefits and limitations of diverse UI elements for T1 diabetes management, and to more precisely identify wider problems with current interaction designs. This led to positing a refined version of Mamykina et al.’s model for diabetes self-management, to account for observed practices, whereby the previously accepted habitual and sensemaking cognitive states are augmented by a posited ‘fluid contextual reasoning’ (FCR) mode, which allows multiple contextual factors to be balanced for dynamic course correction when navigating complex situations, using previously learned knowledge. To investigate user perceptions of the levels and kinds of monitoring anticipated in next generation diabetes decision support systems, a 4-week technology probe, in which participants used multiple networked devices and external data aggregation, was used to frame requirements for user-centered development of such future systems. Integrating all of the above work, an iterative design process was undertaken to create DUETS, a card-based system to facilitate reflection by designers, users, and other stakeholders on diabetes support management systems. The resulting tool and method were then implemented and evaluated through structured sessions with stakeholder focus groups

A personalised and adaptive insulin dosing decision support system for type 1 diabetes

People with type 1 diabetes (T1D) rely on exogenous insulin to maintain stable glucose levels. Despite the advent of diabetes technologies such as continuous glucose monitors and insulin infusion pumps, the majority of people with T1D do not manage to bring back glucose levels into a healthy target after meals. In addition to patient compliance, this is due to the complexity of the decision-making on how much insulin is required. Commercial insulin bolus calculators exist that help with the calculation of insulin for meals but these lack fine-tuning and adaptability. This thesis presents a novel insulin dosing decision support system for people with T1D that is able to provide individualised insulin dosing advice. The proposed research utilises Case-Based Reasoning (CBR), an artificial intelligence methodology, that is able to learn over time based on the behaviour of the patient and optimises the insulin therapy for various diabetes scenarios. The decision support system has been implemented into a user-friendly smartphone-based patient platform and communicates with a clinical platform for remote supervision. In-silico studies are presented demonstrating the overall performance of CBR as well as metrics used to adapt the insulin therapy. Safety and feasibility of the developed system have been assessed incrementally in clinical trials; initially during an eight-hour study in hospital settings followed by a six-week study in the home environment of the user. Human factors play an important role in the clinical adoption of technologies such as the one proposed. System usability and acceptability were evaluated during the second study phase based on feedback obtained from study participants. Results from in-silico tests show the potential of the proposed research to safely automate the process of optimising the insulin therapy for people with T1D. In the six-week study, the system demonstrated safety in maintaining glycemic control with a trend suggesting improvement in postprandial glucose outcomes. Feedback from participants showed favourable outcomes when assessing device satisfaction and usability. A six-month large-scale randomised controlled study to evaluate the efficacy of the system is currently ongoing.Open Acces

iDECIDE: An Evidence-based Decision Support System for Improving Postprandial Blood Glucose by Accounting for Patient’s Preferences

abstract: Type 1 diabetes (T1D) is a chronic disease that affects 1.25 million people in the United States. There is no known cure and patients must self-manage the disease to avoid complications resulting from blood glucose (BG) excursions. Patients are more likely to adhere to treatments when they incorporate lifestyle preferences. Current technologies that assist patients fail to consider two factors that are known to affect BG: exercise and alcohol. The hypothesis is postprandial blood glucose levels of adult patients with T1D can be improved by providing insulin bolus or carbohydrate recommendations that account for meal and alcohol carbohydrates, glycemic excursion, and planned exercise. I propose an evidence-based decision support tool, iDECIDE, to make recommendations to improve glucose control by taking into account meal and alcohol carbohydrates, glycemic excursion and planned exercise. iDECIDE is deployed as a low-cost and easy to disseminate smartphone application. A literature review was conducted on T1D and the state-of-the-art in diabetes technology. To better understand self-management behaviors and guide the development of iDECIDE, several data sources were collected and analyzed: surveys, insulin pump paired with glucose monitoring, and self-tracking of exercise and alcohol. The analysis showed variability in compensation techniques for exercise and alcohol and that patients made unaided decisions, suggesting a need for better decision support. The iDECIDE algorithm can make insulin and carbohydrate recommendations. Since there were no existing in-silico methods for assessing bolus calculators, like iDECIDE, I proposed a novel methodology to retrospectively compare insulin pump bolus calculators. Application of the methodology shows that iDECIDE outperformed the Medtronic insulin pump bolus calculator and could have improved glucose control. This work makes contributions to diabetes technology researchers, clinicians and patients. The iDECIDE app provides patients easy access to a decision support tool that can improve glucose control. The study of behaviors from diabetes technology and self-report patient data can inform clinicians and the design of future technologies and bedside tools that integrate patient’s behaviors and perceptions. The comparison methodology provides a means for clinical informatics researchers to identify and retrospectively test promising insulin blousing algorithms using real-life data.Dissertation/ThesisDoctoral Dissertation Biomedical Informatics 201